Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000238879 | SCV000296904 | uncertain significance | Retinoblastoma | 2015-10-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000238879 | SCV000551819 | likely benign | Retinoblastoma | 2023-12-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001013283 | SCV001173851 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000238879 | SCV004815127 | uncertain significance | Retinoblastoma | 2024-01-11 | criteria provided, single submitter | clinical testing | This variant causes an A to G nucleotide substitution at the +3 position of intron 18 of the RB1 gene. Splice site prediction tools predict that this variant may have a significant impact on RNA splicing, although this prediction has not been confirmed in published RNA studies. This variant has not been reported in individuals affected with RB1-related disorders in the literature. However a different variant at this position has been observed in a patient affected with bilateral retinoblastoma (c.1814+3A>C; PMID: 32218800) and has been classified as pathogenic in ClinVar (Variation ID: VCV000237664). This variant has been identified in 6/249688 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |